Use access key #2 to skip to page content.
$46.98 0.89 (1.93%)
7/3/2008 1:00 PM

Eli Lilly & Co. (LLY)

CAPS Rating:
***

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating LLY

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

444 Outperforms
55 Underperforms
 

All-Stars

148 Outperforms
23 Underperforms
 

Wall Street

11 Outperforms
2 Underperforms
 

Players bullish on LLY are also bullish on:

Players bearish on LLY are also bearish on:

Ticker Tags

Dividend (202), S&P 500 (482), Indianapolis (5), Major 2005 Lawsuit (8), Mega Cap (146), Multinational Company (16), Neuroscience (8), Six Sigma® (37), Drug Manufacturers - Major (27), Indiana (7), Big Pharma (12), Optionable (32)
Suggest a tag

Eli Lilly & Co. At A Glance

Current Price: $46.98
Last Trade Time: 7/3/2008 1:00 PM
Open: $0.00
Previous Close: $46.09
Daily Range: $46.31 - $47.10
52-Week Range: $45.36 - $59.82
Volume: 4,531,256
Market Cap: $52.40B
P/E Ratio: 14.36
Compare Our Special Broker Offers!

Stock Trends

LLY VS S&P 500 (SPY)

LLY 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for LLY

More Headlines...

Top Bull Pitch

Recs

1

Eli Lilly & Co. (LLY)

Avatar kcanant (89.06) Submitted: 3/16/08 5:34 AM

BMW recession-proof stock

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Eli Lilly & Co. (LLY)

Avatar doneb1 (< 20) Submitted: 2/03/08 5:38 PM

class action lawsuit will offset quartly gains probably settle out of court so loss to company will remain unknown

Replies: 0 | Reply | Permalink

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 100 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (LLY)

Avatar chk999longonly (88.17) Submitted: 6/28/08 11:00 PM : Outperform Start Price: $45.77 LLY Score: 3.91

This is at a 52 week low right now.

Quality is on sale

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (LLY)

Avatar lynchangeles (< 20) Submitted: 6/27/08 11:40 AM : Outperform Start Price: $46.18 LLY Score: 3.14

Solid pipeline, product range

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (LLY)

Avatar hmg2 (28.60) Submitted: 6/25/08 3:19 PM : Outperform Start Price: $47.12 LLY Score: 4.34

Stable earnings and dividend growth during period of economic contraction as well as an attractive new product pipeline.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (LLY)

Avatar DrDe1167 (53.86) Submitted: 6/24/08 10:07 PM : Outperform Start Price: $47.03 LLY Score: 4.01

Undervalued at this point in time and is a good buy. Pipeline is starting a bulge even though recent FDA rulings have not been as positive as expected.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (LLY)

Avatar AnomaLee (99.84) Submitted: 6/03/08 5:35 AM : Outperform Start Price: $49.59 LLY Score: -0.25

Last I checked pharmaceutical stocks didn't have toxic securitized mortgages, but the health sector has nearly underperformed the financial sector of the S&P.

Eli Lilly has some big drugs in their pipeline. Developmental results should be in the news, and I'm anxious to see how they perform. America is getting off drugs anytime soon.... That's one war we'll never win

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 100 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 13 of 13  

picks per page. CHANGE Expand All Pitches

Top
Pick
Player NamePlayer RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackRichPzena < 20 06/17/08 Outperform 1Y $48.07-2.27%-7.75%+5.48 Toggle the visibility of 60-Second Pitch and replies
TrackCowenandCo 76.03 06/04/08 Outperform NS $48.62-3.37%-8.39%+5.02
TrackHSBC 93.84 11/05/07 Underperform NS $51.65-9.03%-15.59%-6.56
TrackBRogers 69.30 09/30/07 Outperform NS $55.41-15.22%-17.22%+2.00 Toggle the visibility of 60-Second Pitch and replies
TrackDodgeCox 95.46 09/30/07 Outperform NS $55.41-15.22%-17.22%+2.00 Toggle the visibility of 60-Second Pitch and replies
TrackDreman 94.69 09/30/07 Outperform NS $55.41-15.22%-17.22%+2.00 Toggle the visibility of 60-Second Pitch and replies
TrackHAndW < 20 09/30/07 Outperform NS $55.41-15.22%-17.22%+2.00 Toggle the visibility of 60-Second Pitch and replies
TrackEdwardOwens 98.15 09/30/07 Outperform NS $55.41-15.22%-17.22%+2.00 Toggle the visibility of 60-Second Pitch and replies
TrackBMOCapital 96.78 04/13/07 Outperform NS $54.27-13.43%-12.58%-0.85
TrackJimCramer 83.36 04/04/07 Underperform 3W $52.91-11.20%-12.19%-0.99
TrackMichaelSivy 73.18 03/20/07 Outperform 1Y $51.24-8.31%-10.40%+2.09
TrackAGEdwards 94.66 12/21/06 Outperform NS $49.60-5.29%-11.22%+5.93
TrackFortune2006 64.56 01/03/06 Outperform 1Y $53.78-12.65%-0.74%-11.91

Results 1 - 13 of 13  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners